Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Last updated: June 19, 2022
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bulimia

Cancer

Treatment

N/A

Clinical Study ID

NCT05350007
CANFRADE
  • Ages > 65
  • All Genders

Study Summary

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 65 years or older
  • Conscious and no communication problems
  • Being literate
  • Willing to participate in our study voluntarily
  • Cancer patient receiving active chemotherapy treatment

Exclusion

Exclusion Criteria:

  • Not being willing to participate in the research
  • Serious life-threatening condition (critical illness, intensive care unit stay, acutecomplication)
  • Dementia, Alzheimer's, cognitive dysfunction
  • Major psychiatric illness

Study Design

Total Participants: 180
Study Start date:
May 25, 2022
Estimated Completion Date:
December 31, 2022

Study Description

No studies were found in the literature evaluating the relationship between frailty and lack of social support with tanatophobia and rumination. The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Connect with a study center

  • Sultan Abdülhamid Training and Research Hospital

    Üsküdar, İstanbul 34660
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.